noom and glp-1 Microdosing for Weight Loss Noom Med - GLP-1 Medications
Description
1 As of 2025, roughly 10 million Americans 2 are on GLP-1s, for both treatment of type 2 diabetes and weight loss, and that number is expected to reach 25 million by 2030
A total of 14 years in dedicated schooling and medical residency
Before doing this, I believe its important to explain what a GLP-1 is, why it solves obesity, and the differences between orals and injectables (with their nuances)
(2021) "Once-Weekly Semaglutide in Adults with Overweight or Obesity" The New England Journal of Medicine, 384(11) 5
The drug has a REMS program requiring monthly pregnancy testing in women of reproductive potential
Cardio exercise like walking, running or cycling doesn't appear to meaningfully protect bone during weight loss, Kohrt says
